0
Special Feature |

Picture of the Month FREE

[+] Author Affiliations

Section Editor: Walter W. Tunnessen, MD

More Author Information
Arch Pediatr Adolesc Med. 1998;152(8):826. doi:.
Text Size: A A A
Published online

DENOUEMENT AND DISCUSSION: CONGENITAL PIGMENTED (NEVOCELLULAR) NEVI

Figure 1. A medium-sized congenital pigmented nevus on the right cheek.

Figure 2. A giant hairy nevus involving the scalp, neck, shoulders, and upper back.

Figure 3. A "bathing trunk" nevus with irregular hyperpigmentation.

Figure 4. A giant hairy nevus of the left posterior shoulder area.

CLINICAL AND PATHOLOGIC FEATURES

Congenital pigmented (nevocellular) nevi are present in approximately 1% of newborns.1 The incidence in black infants is higher, 1.8%2 For descriptive purposes, congenital nevi have been arbitrarily classified into 3 categories based on size: small <1.5 cm; medium, 1.5 to 20 cm; and, giant nevi, >20 cm. The congenital nevi that are small to medium typically appear as tan or brown irregularly shaped macules. Over time, the nevi may become elevated and intensely pigmented, sometimes covered with coarse dark hair. 3 Small to medium nevi frequently darken at puberty, with pregnancy, or with the use of oral contraceptives.4

Giant congenital nevi, or giant hairy nevi, occur in 1 in 20000 live births.4,5 They have an irregular margin often with a verrucous surface. Their color is typically dark brown to black and >95% of them have dark, coarse surface hair. Satellite lesions are often present beyond the periphery of the main lesion and may be scattered over the entire skin surface. Around age 10 years, the giant nevus becomes more elevated, verrucous, and hyperkeratotic and the surface hair thicker.6

Giant hairy nevi on the scalp and neck may be associated with leptomeningeal melanocytosis and neurologic disorders that include epilepsy or focal neurologic abnormalities. Lesions over the vertebral column may be associated with spina bifida or meningomyelocele.3 Infants with lesions on the scalp or posterior midline should undergo neuroimaging studies to detect associated conditions that may affect treatment and prognosis.7,8

RISK FOR MALIGNANT CHANGE

Congenital pigmented nevi have a predisposition to undergo malignant change. The size of the lesion correlates with the potential for malignant transformation. The risk of malignant melanoma in patients with small to medium ones ranges from 2.6% to 4.9%, while for giant nevi the risk is felt to be approximately 6%.5 Small congenital nevi pose a much greater practical risk since they occur more frequently than giant nevi. Malignant change of small nevi usually occurs after puberty, whereas 60% of all malignant melanomas arising from giant nevi will develop in the first decade of life.9 In contrast to the greater frequency of congenital nevi in blacks, the frequency of melanoma in blacks is lower than in whites by a factor of 10 to 20.2

MANAGEMENT AND PROGNOSIS

The management of congenital pigmented nevi remains controversial; no absolute guidelines can be recommended. Management is individualized and centers around: cosmetic appearance, risk of neoplastic proliferation, and the psychological impact on the patient and family.

Because it is impractical to prophylactically excise all non–giant congenital nevi, yearly examination for the first 3 years of life is recommended, with reassessment every 2- to 5 years afterward depending on the confidence of the parents to monitor the lesions(s).6 Biopsy specimens are obtained from lesions that undergo suspicious alteration.7

The impact of giant hairy nevi is greater because of the considerable cosmetic disfiguration as well as the higher malignant potential. It is more difficult to recognize early malignant changes within giant pigmented nevi because of their typical irregular surface and pigmentation. Some have recommended total surgical excision as early as technically practical, while others are more cautious because of the large areas involved and the resulting disfigurement and complications from scarring. Due to the depth of some lesions, especially if the leptomeninges are involved, excision may not eliminate the risk for developing melanoma.7 In a prospective study of 92 patients with large lesions, all 3 who subsequently developed melanomas did so in extracutaneous sites.10

Accepted for publication November 9, 1997.

Reprints: Neal P. Simon, MD, Department of Pediatrics, Emory University School of Medicine, Box 2601, Grady Hospital, 80 Butler St, Atlanta, GA 30335-3801.

Rhodes  ARWeinstock  MAFitzpatrick  TB  et al.  Risk factors for cutaneous melanoma: a practical method of recognizing predisposed individuals. JAMA. 1987;2583146- 3154
Shpall  SFrieden  IChesney  MNewman  T Risk of malignant transformation of congenital melanocytic nevi in blacks. Pediatr Dermatol. 1994;11204- 208
Reed  WBBecker Sr  SWBecker  SW  Jr  et al.  "Giant pigmented" nevi, melanomas, and leptomeningeal melanocytosis. Arch Dermatol. 1965;91101- 119
Weston  WLedLane  ATed Color Textbook of Pediatric Dermatology.  St Louis, Mo Mosby–Year Book Inc1991;204- 207239
Rhodes  ARMelski  JW Small congenital nevocellular nevi and the risk of cutaneous melanoma. J Pediatr. 1982;100219- 224
From  L Congenital nevi-let's be practical. Pediatr Dermatol. 1992;9345- 346
Levine  N Pigmentary abnormalities. Schachner  LAHansen  RCeds.Pediatric Dermatology. New York, NY Churchill Livingston Inc1988;545- 549
Frieden  IJWilliams  MLBarkovich  AJ Giant melanocytic nevi: brain magnetic resonance findings in neurologically asymptomatic children. J Am Acad Dermatol. 1994;31423- 429
Kaplan  EW The risk of malignancy in large congenital nevi. Plast Reconstr Surg. 1974;53421- 428
Marghoob  AASchoenbach  SPKopf  AWOrlow  SJNossa  RBart  RS Large congenital melanocytic nevi and the risk for the development of malignant melanoma. Arch Dermatol. 1996;132170- 175

Tables

References

Rhodes  ARWeinstock  MAFitzpatrick  TB  et al.  Risk factors for cutaneous melanoma: a practical method of recognizing predisposed individuals. JAMA. 1987;2583146- 3154
Shpall  SFrieden  IChesney  MNewman  T Risk of malignant transformation of congenital melanocytic nevi in blacks. Pediatr Dermatol. 1994;11204- 208
Reed  WBBecker Sr  SWBecker  SW  Jr  et al.  "Giant pigmented" nevi, melanomas, and leptomeningeal melanocytosis. Arch Dermatol. 1965;91101- 119
Weston  WLedLane  ATed Color Textbook of Pediatric Dermatology.  St Louis, Mo Mosby–Year Book Inc1991;204- 207239
Rhodes  ARMelski  JW Small congenital nevocellular nevi and the risk of cutaneous melanoma. J Pediatr. 1982;100219- 224
From  L Congenital nevi-let's be practical. Pediatr Dermatol. 1992;9345- 346
Levine  N Pigmentary abnormalities. Schachner  LAHansen  RCeds.Pediatric Dermatology. New York, NY Churchill Livingston Inc1988;545- 549
Frieden  IJWilliams  MLBarkovich  AJ Giant melanocytic nevi: brain magnetic resonance findings in neurologically asymptomatic children. J Am Acad Dermatol. 1994;31423- 429
Kaplan  EW The risk of malignancy in large congenital nevi. Plast Reconstr Surg. 1974;53421- 428
Marghoob  AASchoenbach  SPKopf  AWOrlow  SJNossa  RBart  RS Large congenital melanocytic nevi and the risk for the development of malignant melanoma. Arch Dermatol. 1996;132170- 175

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics